We analyzed the percent-positivity of these and other markers on CD14+, CD16+, and CD83+CD14+ monocytes, and observed upregulation of these markers among COVID-19 patients compared to healthy donors across multiple monocytes states (Fig. 2D–E and Supplementary Fig. 19A). The gene discussed is CD14; the disease is COVID-19.